Since then, fusions, mutations, and alternative splicing of ALK have been successively detected in other cancers, such as NSCLC, digestive tract cancer, renal cell carcinoma, breast cancer, thyroid cancer, and ovarian cancer, among others (7–9). Here, ALK is linked to non-small cell lung carcinoma.